Skip to content

In-person clinical research without drug or device therapeutic benefit will pause effective Nov. 23

Given the rapid acceleration of the prevalence of COVID-19 locally and across Pennsylvania, effective Nov. 23 for Penn State College of Medicine and all Penn State Health sites, studies involving in-person interaction with participants with no direct drug or device therapeutic benefit must pause.

Research interactions with participants such as telephone contact, remote monitoring or remote data collection may continue.

Any observational study (whether inpatient or outpatient) that requires any additional in-person contact with subjects must be postponed until further notice.

This decision has been made by Interim Dean Kevin Black, MD, and Vice Dean for Research and Graduate Studies Leslie Parent, MD, in consultation with researchers and College leadership.

See the full revised standards for clinical research here

Important links

If you're having trouble accessing this content, or would like it in another format, please email the Penn State College of Medicine web department.